Ocular changes due to the treatment of juvenile systemic lupus erythematosus

Revista Brasileira de Reumatologia

Volumn 51, Issue 6, 2011, Pages 550-557

  Fraga, Melissa Mariti ^a   Len, Claudio Arnaldo ^a   dos Santos Finamor, Luciana Peixoto ^a   Matos, Kimble Teixeira Fonseca ^a   Muccioli, Cristina ^a   Hilário, Maria Odete Esteves ^a   Terreri, Maria Teresa Ramos Ascenso ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Adolescent; Autoimmune Diseases; Eye; Glucocorticoids

Indexed keywords

CHLOROQUINE; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE;

ADOLESCENT; ARTICLE; CATARACT; CHILD; CORTICOSTEROID THERAPY; DISEASE COURSE; DRUG PULSE THERAPY; DRUG WITHDRAWAL; EYE DISEASE; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OCULAR HYPEREMIA; OCULAR PRURITUS; ONSET AGE; OPHTHALMOSCOPY; PAPILLEDEMA; PRESCHOOL CHILD; RETINA MACULA LUTEA; SCHOOL CHILD; SIDE EFFECT; SUBCAPSULAR CATARACT; SYSTEMIC LUPUS ERYTHEMATOSUS; TERTIARY HEALTH CARE; TREATMENT DURATION; CHEMICALLY INDUCED DISORDER; RETROSPECTIVE STUDY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; EYE DISEASES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; RETROSPECTIVE STUDIES;

EID: 82955240529     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Cassidy JT, Sullivan DB, Petty RE, Rasgale C. Lupus nephritis and encephalopathy. Prognosis in 58 children. Arthritis Rheum 1977; 20(2 Suppl):315-22.
2. Norris DG, Colón AR, Stickler GB. Systemic lupus erythematosus in children: the complex problems of diagnosis and treatment encountered in 101 such patients at the Mayo Clinic. Clin Pediatr (Phila) 1977; 16(9):774-8.
3. Hagge WW, Burke EC, Stickler GB. Treatment of systemic lupus erythematosus complicated by nephritis in children. Pediatrics 1967; 40(5):822-7.
4. Celermajer DS, Thorner PS, Baumal R, Arbus GS. Sex differences in childhood lupus nephritis. Am J Dis Child 1984; 138(6):586-8.
5. Cook CD, Wedgwood RJP, Craig JM, Hartmann JR, Janeway C. Systemic lupus erythematosus. Description of 37 cases in children and a discussion of endocrine therapy in 32 of the cases. Pediatrics 1960; 26:570-85.
6. Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH. Systemic lupus erythematosus: a review of the literature and clinical analysis of 138 cases. Medicine (Baltimore) 1954; 33(4):291-437.
7. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfeld NF et al. The 1982 revised criteria for the classifcation of systemic lupus erythematosus. Arthritis Rheum 1982; 25(11):1271-7.
8. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classifcation of systemic lupus erythematosus. Arthritis Rheum 1997; 40(9):1725.
9. Yap EY, Au Eong KG, Fong KY, Howe HS, Boey ML, Cheah WM et al. Ophthalmic manifestations in Asian patients with systemic lupus erythematosus. Singapore Med J 1998; 39(12):557-9.
10. Vine AK, Barr CC. Proliferative lupus retinopathy. Arch Ophthalmol 1984; 102(6):852-4.
11. Jabs DA, Fine SL, Hochberg MC, Newman SA, Heiner GG, Stevens MB. Severe retinal vaso-oclusive disease in systemic lupus erythematosus. Arch Ophthalmol 1986; 104(4):558-63.
12. Coppeto J, Lessell S. Retinopathy in systemic lupus erythematosus. Arch Ophthalmol 1977; 95(5):794-7.
13. Sivaraj RR, Durrani OM, Denniston AK, Murray PI, Gordon C. Ocular manifestations of systemic lupus erythematosus. Rheumatology (Oxford) 2007; 46(12):1757-62.
14. Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29(2):288-91.
15. Gladman DD, Ginzler E, Goldsmith C, Fortin P, Liang M, Sanchez-Guerrero J et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996; 39(3):363-9.
16. Sociedade Brasileira de Cardiologia, Sociedade Brasileira de Hipertensão, Sociedade Brasileira de Nefrologia. V Diretrizes Brasileiras de Hipertensão Arterial. Rev Bras Hipertens 2006; 13(4):260-312.
17. Al-Mayouf SM, Al-Hemidan AI. Ocular manifestations of systemic lupus erythematosus in children. Saudi Med J 2003; 24(9):964-6.
18. Asherson RA, Merry P, Acheson JF, Harris EN, Hughes GR. Antiphospholipid antibodies: a risk factor for occlusive vascular disease in systemic lupus erythematous and the 'primary' antiphospholipid syndrome. Ann Rheum Dis 1989; 48(5):358-61.
19. Mendes LE, Gonçalves JOR, Costa VP, Belfort Jr R. Alterações oculares no lúpus eritematoso sistêmico. Arq Bras Oftalm 1998; 61(6):713-6.
20. Porto RB, Cestari ST, Pereira ERH, Tomazini P, Brambilla LC, Mauro Filho GL et al. Ceratoconjuntivite sicca em lúpus eritematoso sistêmico. Rev Bras Reumatol 1996; 36(1):25-8.
21. Almeida RT, Aikawa NE, Sallum AM, Jesus AA, Sá LC, Silva CA. Irreversible blindness in juvenile systemic lupus erythematosus. Lupus 2011; 20(1):95-7.
22. Bigolin S, Oyamaguchi E, Claro C Del, Bryk Jr A, Komatsu MCG, Belotto E et al. Achados oculares e fundoscópicos em pacientes com lúpus eritematoso sistêmico. Arq Bras Oftalmol 2000; 63(5):383-6.